BioSpace News Archive

Selected projects to reach more than 18,000 students nationwide in grade 6 through college

With more than three million implants worldwide, buttressing material improves patient outcomes by reducing potentially life-threatening complications that can occur after bariatric weight-loss procedures

Milliman, Inc., the premier global consulting and actuarial firm, today announced that Physicians Insurance A Mutual Company has selected Milliman Datalytics-Defense® as its advanced analytics legal management platform for processing defense cost invoices.

Jing Tu has been selected as the 2018 winner of the Bioanalysis Rising Star Award, selected from among 30 nominees across the globe.

Devonian Health Group Inc. announces the recognition of Sybil Dahan, President of Altius Healthcare - commercial division of Devonian - as an inductee into the 2018 Canadian Healthcare Marketing Hall of Fame.

Castle Connolly Private Health Partners, LLC (“CCPHP”), a leading membership-based (or “concierge”) practice conversion and support company, is pleased to announce a collaboration with Dr. Richard R. Bobé to establish a concierge practice.

PolyPid Ltd., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, locally administered therapies for post-surgical complications, announced today that the United States Food and Drug Administration (FDA) has completed its review of the IND and indicated that PolyPid may proceed with its phase 3 clinical trial of its lead asset D-PLEX[

Nurx, a consumer health company offering easy online access to physicians and seamless delivery of medications, today announced Former U.S. Surgeon General Dr. Regina Benjamin, MD, MBA will join the telemedicine company’s board of directors.

Combined Insurance, a leading provider of individual supplemental accident, disability, health, and life insurance products, and a Chubb company, held a veteran employment summit and panel discussion alongside Luke’s Wings, a military-veteran charitable partner of the company.

The clinical utility of quantitative metrics produced by MRCP+ for discriminating biliary disease was the focus of several abstracts accepted for presentation, here, at the American Association for the Study of Liver Disease’s The Liver Meeting® 2018,